Sun Pharmaceuticals

Med Labs Diagnostics is a facial plastic surgery practice based in Rutherford, NJ, offering a range of surgical and non-invasive treatments to help patients achieve a more youthful appearance. With a commitment to personalized care and patient satisfaction, their team of experienced surgeons and medical professionals provide the latest technology in laser treatments, injectables, and aesthetic procedures, such as microdermabrasion and chemical peels, to enhance and rejuvenate the skin. Led by Dr. Janet M. Neigel and Dr. Michael J. Richard, Med Labs Diagnostics is dedicated to building long-lasting relationships with their patients, providing superior surgical care, expert skin care, and patient education in a safe and private environment. Their goal is to help individuals feel more confident and achieve beautiful skin for life through their comprehensive range of services.Generated from the website

Founded in 1946, URL Pharma Inc. is a research and technology-driven, proprietary-branded pharmaceutical business. Formed as United Research Laboratories, it gained its current name in 2008. URL Pharma Inc.'s research focuses on developing scientific and medical innovations for existing compounds to serve unmet medical needs. With more than 60 years of operating history, it has a diversified product portfolio, including a deep, mid-to-late-stage branded product and technology pipeline. The company markets four branded prescription medications. URL Pharma Inc. successfully commercialized its first internally developed branded product in 2006. The company s overall Research and Development (R&D) budget for 2008 expectedly exceeded $60 million.

Prolong Pharmaceuticals, LLC, based in South Plainfield, NJ, is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for complex diseases, including ischemia, hypoxia within stroke, sickle cell disease, and cystic fibrosis. With a leadership team experienced in biotechnology and a pioneering approach to PEGylation, Prolong aims to meet critical unmet medical needs through its cutting-edge biopharma solutions. The company's flagship product, PP-007 Sanguinate, employs a novel PEGylated technology to restore homeostasis by delivering oxygen to hypoxic tissues and facilitating improved perfusion while reducing inflammation. Prolong Pharmaceuticals is committed to advancing healthcare through groundbreaking therapies targeting severe and life-threatening conditions, with a strong focus on addressing the global health issue of stroke. Generated from the website